Entity

Time filter

Source Type

Hradec Králové, Czech Republic

Pitelinova J.,Oddeleni klinicke biochemie | Solcova L.,Oddeleni klinicke biochemie | Tichy M.,Ustav Klinicke Biochemie A Diagnostiky LF UK A FN
Klinicka Biochemie a Metabolismus | Year: 2011

There is significant recurrent discrepance between elevated fasting plasma glukose and glycohemoglobin in a patient with diabetes mellitus type 1. The fall in glycohemoglobin results is due to short life span of erythrocytes as a product of dapson-induced hemolysis. Fructosamine concentrations is more appropriate to control diabetes mellitus in this case, because is not affected by hemolysis.


Friedecky B.,Ustav Klinicke Biochemie A Diagnostiky LF UK A FN
Klinicka Biochemie a Metabolismus | Year: 2010

The objective of this review are data of current state in frequency, detection and evaluation of errors in clinical laboratories obtained by studying the recent literature. There are introduced data from all phases of laboratory examinations - preanalytical, analytical and postanalytical. Their possible negative effects on the level of health care and on the risk for patients are analysed. Also connections between numbers and kinds of errors with patient's health care are described. Accreditation standards, personal responsibilities and creation of quality indicators systems are another part of this review.


Pudil R.,1. Interni Klinika LF UK a FN | Tichy M.,Ustav Klinicke Biochemie A Diagnostiky LF UK A FN
Klinicka Biochemie a Metabolismus | Year: 2010

Natriuretic peptides play an important role in heart failure. The review focuses on biology of natriuretic peptides, their role in pathophysiology of heart failure. The authors comment their use in diagnosis both systolic and diastolic heart failure, and their role in monitoring of the therapy. Furthermore, the authors discuss the significance of natriuretic peptide assessment in pulmonary embolism. The therapeutic experiments using natriuretic peptides and their analogues in patients with heart failure are discussed.


Pudil R.,I. interni kardioangilogicka klinika LF UK a FN | Praus R.,I. interni kardioangilogicka klinika LF UK a FN | Hulek P.,II. interni gastroenterologicka klinika LF UK a FN | Safka V.,I. interni kardioangilogicka klinika LF UK a FN | And 3 more authors.
Intervencni a Akutni Kardiologie | Year: 2013

Purpose: Liver cirrhosis is associated with hyperdynamic circulation which can result in heart failure. Transjugular intrahepatic portosystemic shunt (TIPS) due to increase of cardiac output is a stressful stimulus for cardiovascular system. Therefore, new methods for early detection of heart failure are needed. The aim of the study was to analyze the effect of TIPS procedure on hemodynamic. Material and Methods: 55 patients (38 men and 17 women, 55.6 ± 8.9 years) with liver cirrhosis treated with TIPS were enrolled in the study. Echocardiography was performed before, 24 hours, 7, 30 and 180 days after the procedure. Results: Left ventricular end-diastolic diameter (LVEDD) was increasing [before: median 47 (interquartile range: 44.7-51.2) mm, day 7: 50 (46.5-51.3) mm, p < 0.05; day 30: 49.5 (46.7-55.2) mm, p < 0.01; day 180: 52.5 (48.3-55.2) mm, p < 0.01)]. We noticed increase in vena cava inferior (VCI) diameter [before: 17 (15.5-19) mm, 24 h: 17 (15.5-19), p ns; day 7: 18 (16.3-19.4), p ns; day 30: 18.7 (16.5-19.8) mm, p < 0.05; day 180: 19 (18.2-20.5), p < 0.05]. Right ventricular (RV) diameter was increasing [before: 27 (25-29) mm, 24 h: 28 (26-30) mm, p ns; day 7: 29 (27.5-30) mm, p < 0.05; day 30: 30 (27-31) mm, p < 0.05; day 180: 30 (27.5-31.2), p < 0.05]. Transmitral E wave significantly was increasing [before: 75,5 (60.5-87.3) cm/s, 24 h: 88 (74.3-109.7), p < 0.01; day 7: 89 (81.5-105) p < 0.01; 1 month: 94 (82.7-108.5) p < 0.01; 6 months: 91 (80.1-120.2) p < 0.01]. The E/A ratio was increasing during the follow up (baseline: 0.88, 24 h after: 0.89, 1 week: 1.0, 30 days: 1.13, 6 month: 1.06 p < 0.01). Conclusion: Hemodynamic changes following TIPS procedure can be monitored using echocardiography. Transmitral flow analysis can serve as a useful tool for evaluating of diastolic function in these patients. Copyright 2009 © Solen s.r.o.


Plisek S.,Klinika Infekcnich Nemoci LF UK a FN | Pliskova L.,Ustav Klinicke Biochemie A Diagnostiky LF UK A FN | Bolehovska R.,Ustav Klinicke Biochemie A Diagnostiky LF UK A FN | Kapla J.,Klinika Infekcnich Nemoci LF UK a FN | Stepanova V.,Ustav Klinicke Mikrobiologie LF UK A FN
Klinicka Biochemie a Metabolismus | Year: 2010

Our work analyzes the group of 93 patients with chronic hepatitis C under treatment some of these patients have passed the antiviral therapy repeatedly, with the view of the possibility to determine the prediction of the therapy success. Using the statistical data processing, especially ROC analysis, we tried to define the predictive factors that may help the physician prior to antiviral therapy introduction or already during the ongoing therapy to predict the probability to reach the sustained viral response (SVR) in the patient. According to our findings we conclude that the crucial for SVR prediction is the monitoring of HCV viremia level 7 days and 3 months after the introduction of antiviral therapy. The monitoring of ALT activity, especially ALT/AST ratio prior to therapy introduction, after 4 weeks of ongoing therapy and the decrease of ALT activity after 4 weeks of ongoing therapy enables the satisfactory ratio of prediction. HCV viremia level determination prior to therapy introduction and detection of the decrease of its level after 7 days and 3 months of ongoing therapy belong to factors (parameters), which may satisfactory predict SVR. The monitoring of leucocytes count decrease after 4 weeks of therapy and the neutrophiles count prior to therapy introduction and its decrease after 4 weeks of therapy belong to well-founded factors in SVR prediction as well. High hematotoxicity reflects better interferon therapy efficacy. On the other hand BMI, albumin and bilirubin levels are factors that did not show evidence of any prediction value of SVR in our patients.

Discover hidden collaborations